Respiratory viruses: their importance and lessons learned from COVID-19

C Cilloniz, CM Luna, JC Hurtado… - European …, 2022 - Eur Respiratory Soc
Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory
failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is …

Sphingolipids in lung pathology in the coronavirus disease era: A review of sphingolipid involvement in the pathogenesis of lung damage

SA Khan, KF Goliwas, JS Deshane - Frontiers in Physiology, 2021 - frontiersin.org
Sphingolipids are bioactive lipids involved in the regulation of cell survival, proliferation, and
the inflammatory response. The SphK/S1P/S1PR pathway (S1P pathway) is a driver of many …

Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach

L Lu, LP Liu, R Gui, H Dong, YR Su, XH Zhou… - Frontiers in …, 2022 - frontiersin.org
Corona Virus Disease 2019 (COVID-19), an acute respiratory infectious disease caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread rapidly …

Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients

MB Azaiz, AB Jemaa, W Sellami, C Romdhani… - Immunobiology, 2022 - Elsevier
The severity of COVID-19 is largely determined by the inflammatory response, a “Cytokine
storm,” that involves both pro-and anti-inflammatory cytokines. In the current study we …

[HTML][HTML] Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19

PI Lee, PR Hsueh - Journal of Microbiology, Immunology and Infection, 2023 - Elsevier
Multisystem inflammatory syndrome in children (MIS-C) is a dysregulated autoimmune-
mediated illness in genetically susceptible patients following COVID-19 with an interval of 2 …

COVID‐19‐associated liver injury: Adding fuel to the flame

Y Wang, M Shen, Y Li, J Shao, F Zhang… - Cell Biochemistry …, 2023 - Wiley Online Library
COVID‐19 is mainly characterized by respiratory disorders and progresses to multiple organ
involvement in severe cases. With expansion of COVID‐19 and SARS‐CoV‐2 research …

[HTML][HTML] Inhalable chitosan-based hydrogel as a mucosal adjuvant for hydroxychloroquine in the treatment for SARS-CoV-2 infection in a hamster model

DSH Lin, SC Tzeng, TL Cha, CM Hung, WC Lin… - Journal of Microbiology …, 2023 - Elsevier
Background Effective therapy for COVID-19 remains limited. Hydroxychloroquine (HCQ) has
been considered, but safety and efficacy concerns remain. Chitosan exhibits antiviral and …

[HTML][HTML] Efficacy, safety, and serum cytokine modulation by olopatadine hydrochloride and desloratadine citrate disodium combination therapy in urticaria

JP Xu, XB Zhang, QX Jiang, XY Wang… - American Journal of …, 2024 - ncbi.nlm.nih.gov
Objectives: To assess the efficacy, safety, and impact on serum cytokines of olopatadine
hydrochloride (OLP) combined with desloratadine citrate disodium (DES) in treating …

Comparison of Changes in Inflammation Markers NLR, CRP, and LCR after Corticosteroid Therapy in Severe and Critical COVID-19 Patients

LV Ayuningtyas, AA Hermosaningtyas… - Trends in …, 2024 - tis.wu.ac.th
Corticosteroid, an immunomodulator agent for treating hyperinflammation, is widely used in
severe and critical COVID-19 patients. This study is a retrospective observational cohort …

Secuelas psicoafectivas asociadas a insomnio en pacientes infectados por coronavirus Piura 2021

VY Remicio Saavedra - 2024 - repositorio.upao.edu.pe
Objetivo: El objetivo del presente estudio es determinar las secuelas psicoafectivas
asociadas a insomnio en pacientes post-COVID19. Materiales y métodos: Se realizo un …